Other ingredients: vegetarian capsule (hydroxypropyl methylcellulose, water) and ascorbyl palmitate
The pharmacokinetic advantage is significant: systemic bioavailability of intranasal peptides is typically 1020%, but CNS bioavailability can reach 3060% because the compound travels directly along nerve sheaths into cerebrospinal fluid
BPC-157 at a Glance BPC-157 has a defined sequence and a sizeable preclinical literature
The therapy involved an intragastric bolus, and continuous oral application in drinking water, activated azygos vein direct blood delivery, counteracted/attenuated the intracranial (superior sagittal sinus), portal and caval hypertension, aortal hypotension, multiorgan failure (brain, heart, lung, liver, kidney, stomach, and intestinal lesions), and progressing thrombosis